ASP Isotopes Stock Rockets As TerraPower Deal Ignites Retail Buzz

Shares of ASP Isotopes ($ASPI) surged nearly 45% on Wednesday morning following news of a term sheet agreement with TerraPower, a prominent nuclear innovation company. 

If gains hold, the stock could be on for a record close as well as its best day ever. 

The agreement outlines plans for constructing a uranium enrichment facility to produce High Assay Low-Enriched Uranium (HALEU) for future supply to TerraPower, a customer of Quantum Leap Energy (QLE). 

The announcement quickly made ASPI one of the top 5 trending tickers on Stocktwits.

The small-cap stock has notched a 330% increase in followers and a remarkable 1,600% spike in message volume on the social media platform over the past year.

Earlier in October, Canaccord Genuity analyst George Gianarikas reaffirmed a ‘Buy’ rating on ASPI, setting a price target of $4.50 — which the stock has crossed already.

Gianarikas emphasized ASP’s potential to reduce Western dependence on Russia’s uranium supply chain, while highlighting the company’s innovative enrichment technology, which may advance nuclear medicine and semiconductor technology markets. 

ASP’s recent early production of laser-enriched ytterbium-176 marks a crucial milestone, anticipated to add approximately $20 million in annual revenue, according to the brokerage.

ASP’s quantum enrichment technology not only validates its cutting-edge approach but also positions the company as a key player in the HALEU supply chain, which is critical to advanced nuclear fuel development. 

These developments are significant because technology giants are increasingly turning to nuclear energy to power the data centers that train and run the large artificial intelligence models behind today’s generative AI applications.

ASP Isotope points out the rising demand for isotopes like Silicon-28 for quantum computing, Molybdenum-100, Molybdenum-98, Zinc-68, Ytterbium-176, and Nickel-64 for emerging healthcare applications, and Chlorine-37, Lithium-6, Lithium-7, and Uranium-235 for green energy initiatives.

So far in 2024, ASP stock has more than tripled, far outpacing the benchmark S&P 500 and Nasdaq indices.

For updates and corrections, email newsroom@stocktwits.com

Read next: Eli Lilly Stock Slides Pre-Market On Weight-Loss Drug Sales Miss, But Retail Eyes Buying Opportunity

Share

·

Add us on